Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B. Pappalardi, Rab K. Prinjha, Jacques Briand et al.|Nature Cancer|2021Cited by 279
Identifying drug targets in tissues and whole blood with thermal-shift profilingJessica Perrin, Giovanna Bergamini, Thilo Werner et al.|Nature Biotechnology|2020Cited by 195
Cell surface thermal proteome profiling tracks perturbations and drug targets on the plasma membraneMathias Kalxdorf, Marcus Bantscheff, Ina Günthner et al.|Nature Methods|2021Cited by 92
Proteome thermal stability reflects organ physiology and identifies drug-target engagement in vivoJessica Perrin, Giovanna Bergamini, Thilo Werner et al.|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 5